.JPG "HuidaGene's First CRISPR RNA-Editing Therapy for nAMD Cleared by US FDA")
HuidaGene Therapeutics (HuidaGene), a worldwide biotech company focused on genome medicines in clinical trials, revealed that the US FDA has approved its HG202 investigational new drug (IND) application for neovascular age-related macular...
Protega Pharmaceuticals Inc., a unique specialty pharmaceutical company dedicated to ethical pain control and creating new abuse-resistant products, revealed that the US Food and Drug Administration (FDA) has given the green light for Roxybond...
A graphene-based brain chip is entering its first clinical trial at Salford Royal Hospital, aiming to revolutionize brain tumor surgeries, according to The Guardian. The device, roughly postage-stamp sized, works by detecting cancer cells through ...
Dr. Puranik was addressing the second Foundation Day celebration of the Indian Ayurvedic Medical College (IAMC) at the University of Science and Technology Meghalaya (USTM)...
The government has instructed companies to reduce the prices of three anti-cancer drugs in order to pass on the benefits from customs duty exemptions and reductions in GST to consumers. In line with the government’s commitment to ensuring that dru...
Lyfius Pharma, a unit of Aurobindo Pharma, on Tuesday said Prime Minister Narendra Modi has inaugurated its Penicillin-G plant at Kakinada, Andhra Pradesh. The facility with an annual production capacity of 15,000 metric tonnes (MT) was virtually ...
Emcure Pharmaceuticals Limited has announced the formation of a wholly-owned subsidiary, Emcutix Biopharmaceuticals Limited, which will focus exclusively on dermatology...
Medicines for Malaria Venture (MMV) and Quotient Sciences have begun the first clinical trial for a long-acting injectable (LAI) preventive compound for malaria. The trial, conducted in healthy volunteers in Nottingham, UK, marks a significant...
In the previous year, approximately half of India’s pharmaceutical and biological products were sent overseas, signaling a significant change towards a pharmaceutical industry focused on exports as India nears exporting over 50% of its output...
Tyra Biosciences, Inc., a biotechnology company in the clinical development stage, revealed that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for TYRA-300, enabling the company to move...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")